Two reports showed that AITL shared the same TET2 mutations with the isolated CD20+/CD19+ (B-cells) or CD34+ cells (Couronné et al., 2012; Schwartz et al., 2017). Here, TET2 is linked to angioimmunoblastic T-cell lymphoma.